Rempfer v. Sharfstein, No. 08-5117
In an action challenging the Food and Drug Administration's approval of an anthrax vaccine and seeking to enjoin the Defense Department from administering it to military personnel, dismissal of the complaint is affirmed where: 1) the court deferred to the FDA's judgment that the vaccine was effective regardless of the route of exposure; and 2) the FDA did not act arbitrarily or capriciously in resting a finding of effectiveness on the results of a challenged study.
Argued April 20, 2009
Decided September 29, 2009